BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11773397)

  • 1. Mutations of the woodchuck hepatitis virus polymerase gene that confer resistance to lamivudine and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.
    Yamamoto T; Litwin S; Zhou T; Zhu Y; Condreay L; Furman P; Mason WS
    J Virol; 2002 Feb; 76(3):1213-23. PubMed ID: 11773397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine.
    Tatti KM; Korba BE; Stang HL; Peek S; Gerin JL; Tennant BC; Schinazi RF
    Antiviral Res; 2002 Jul; 55(1):141-50. PubMed ID: 12076758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine.
    Zhou T; Saputelli J; Aldrich CE; Deslauriers M; Condreay LD; Mason WS
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1947-54. PubMed ID: 10428918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
    Peek SF; Cote PJ; Jacob JR; Toshkov IA; Hornbuckle WE; Baldwin BH; Wells FV; Chu CK; Gerin JL; Tennant BC; Korba BE
    Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
    Jacob JR; Korba BE; Cote PJ; Toshkov I; Delaney WE; Gerin JL; Tennant BC
    Antiviral Res; 2004 Aug; 63(2):115-21. PubMed ID: 15302140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.
    Chin R; Shaw T; Torresi J; Sozzi V; Trautwein C; Bock T; Manns M; Isom H; Furman P; Locarnini S
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2495-501. PubMed ID: 11502520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
    Le Guerhier F; Pichoud C; Jamard C; Guerret S; Chevallier M; Peyrol S; Hantz O; King I; Trépo C; Cheng YC; Zoulim F
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1065-77. PubMed ID: 11257017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis.
    Zhu Y; Yamamoto T; Cullen J; Saputelli J; Aldrich CE; Miller DS; Litwin S; Furman PA; Jilbert AR; Mason WS
    J Virol; 2001 Jan; 75(1):311-22. PubMed ID: 11119601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virus.
    Zhu Y; Cullen JM; Aldrich CE; Saputelli J; Miller D; Seeger C; Mason WS; Jilbert AR
    Virology; 2004 Sep; 327(1):26-40. PubMed ID: 15327895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infection.
    Jacquard AC; Nassal M; Pichoud C; Ren S; Schultz U; Guerret S; Chevallier M; Werle B; Peyrol S; Jamard C; Rimsky LT; Trepo C; Zoulim F
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2683-92. PubMed ID: 15215126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S; Cote PJ; Korba BE; Butler SD; George AL; Tochkov IA; Delaney WE; Xiong S; Gerin JL; Tennant BC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection.
    Menne S; Roneker CA; Tennant BC; Korba BE; Gerin JL; Cote PJ
    Intervirology; 2002; 45(4-6):237-50. PubMed ID: 12566706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.
    Lu M; Hilken G; Yang D; Kemper T; Roggendorf M
    J Virol; 2001 Apr; 75(8):3811-8. PubMed ID: 11264370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection.
    Menne S; Roneker CA; Korba BE; Gerin JL; Tennant BC; Cote PJ
    J Virol; 2002 Jun; 76(11):5305-14. PubMed ID: 11991959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral administration of emtricitabine on woodchuck hepatitis virus replication in chronically infected woodchucks.
    Korba BE; Schinazi RF; Cote P; Tennant BC; Gerin JL
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1757-60. PubMed ID: 10817750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.
    Korba BE; Cote P; Hornbuckle W; Schinazi R; Gangemi JD; Tennant BC; Gerin JL
    Antivir Ther; 2000 Jun; 5(2):95-104. PubMed ID: 10971862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of mutations in woodchuck hepatitis virus enhancer II.
    Wei Y; Tennant B; Ganem D
    J Virol; 1998 Aug; 72(8):6608-13. PubMed ID: 9658106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
    Korba BE; Cote P; Hornbuckle W; Tennant BC; Gerin JL
    Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent.
    Chu CK; Boudinot FD; Peek SF; Hong JH; Choi Y; Korba BE; Gerin JL; Cote PJ; Tennant BC; Cheng YC
    Antivir Ther; 1998; 3(Suppl 3):113-21. PubMed ID: 10726061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamivudine therapy of WHV-infected woodchucks.
    Mason WS; Cullen J; Moraleda G; Saputelli J; Aldrich CE; Miller DS; Tennant B; Frick L; Averett D; Condreay LD; Jilbert AR
    Virology; 1998 May; 245(1):18-32. PubMed ID: 9614864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.